Adams Diversified Equity Fund’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Adams Diversified Equity Fund’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,800	Closed	-$107K	–	220
2019 Q2	$107K	Sell	1,800 -1,200	-40%	-$75.5K	0.01%	202
2019 Q1	$187K	Sell	3,000 -5,100	-63%	-$337K	0.01%	211
2018 Q4	$491K	Sell	8,100 -1,600	-16%	-$95.6K	0.03%	156
2018 Q3	$567K	Buy	+9,700	New	+$495K	0.03%	185
2017 Q3	–	Sell	-12,500	Closed	-$619K	–	230
2017 Q2	$619K	Sell	12,500 -2,400	-16%	-$126K	0.03%	201
2017 Q1	$817K	Buy	14,900 +400	+3%	+$21.2K	0.05%	194
2016 Q4	$808K	Buy	14,500 +7,700	+113%	+$370K	0.05%	187
2016 Q3	$272K	Hold	6,800	–	–	0.02%	185
2016 Q2	$272K	Buy	+6,800	New	+$249K	0.02%	185

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adams Diversified Equity Fund's BSTC Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2019, closing a stake of 1,800 shares — an estimated $107K sold.

Adams Diversified Equity Fund first reported a position in BSTC in Q2 2016 and held it in 9 quarters. The position peaked at $817K in Q1 2017. 114 funds tracked by Wall St. Rank hold BSTC as of Q3 2019.

Adams Diversified Equity Fund reported no remaining BioSpecifics Technologies Corp. position as of Q3 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 1,800 BioSpecifics Technologies Corp. shares in Q3 2019, an estimated $107K.
Adams Diversified Equity Fund first reported a position in BioSpecifics Technologies Corp. in Q2 2016 and held it in 9 quarters.
Adams Diversified Equity Fund's BioSpecifics Technologies Corp. position peaked at $817K in Q1 2017.
114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.